Latest papers

A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana.

Protecting children from HPV: challenges and opportunities.

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2.

Knowledge of cervical cancer, pap testing and the human papillomavirus among young Australian women.

How to prevent cervical cancer.

Human papillomavirus: clinical manifestations and prevention.

[Papillomavirus and cancer: new lights].

The path to developing a cervical cancer vaccine.

Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.

Emerging oral cancer subtype draws concern.

Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine.

For debate: that Australia should consider changing to the bivalent vaccine.

Human papilloma vaccination to adolescents.

For debate: that Australia should continue using the quadrivalent vaccine.

Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role.

Commentary on opinion pieces re Australian human papillomavirus vaccine policy.

The India HPV-vaccine suspension.

Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 years.

Child and adolescent immunization. Current issues and updates.

Human papillomavirus vaccines in plants.